A carregar...
Immunotherapy for Gastroesophageal Cancer
Survival for patients with advanced oesophageal and stomach cancer is poor; together these cancers are responsible for more than a million deaths per year globally. As chemotherapy and targeted therapies such as trastuzumab and ramucirumab result in modest improvements in survival but not long-term...
Na minha lista:
| Publicado no: | J Clin Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5086586/ https://ncbi.nlm.nih.gov/pubmed/27669318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm5100084 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|